ATP2C2 and invasive breast carcinoma: Here we set out to compare differentially expressed genes (DEGs) produced by comparison between stromal components and immune components in BRCA cases, revealing that the ATP2C2 may be a potential indicator for the alteration of TME status in BRCA.